TLX Annual CFF
$6.76 M
-$114.76 M-94.44%
01 December 2023
Summary:
As of January 21, 2025, TLX annual cash flow from financing activities is $6.76 million, with the most recent change of -$114.76 million (-94.44%) on December 1, 2023. During the last 3 years, it has fallen by -$16.81 million (-71.32%). TLX annual CFF is now -94.44% below its all-time high of $121.52 million, reached on December 1, 2022.TLX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TLX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -94.4% | - | - |
| 3 y3 years | -71.3% | - | - |
| 5 y5 years | +1141.5% | - | - |
TLX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.4% | +216.4% | ||||
| 5 y | 5-year | -94.4% | +216.4% | ||||
| alltime | all time | -94.4% | +1141.5% |
Telix Pharmaceuticals Limited Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $6.76 M(-94.4%) | - | - |
| Dec 2022 | $121.52 M(+5585.9%) | - | - |
| Dec 2021 | $2.14 M(-90.9%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $23.58 M(-20.6%) | - | - |
| Dec 2019 | $29.70 M(-4674.2%) | - | - |
| Dec 2018 | -$649.30 K(-101.5%) | - | - |
| Dec 2017 | $41.98 M | - | - |
FAQ
- What is Telix Pharmaceuticals Limited annual cash flow from financing activities?
- What is the all time high annual CFF for Telix Pharmaceuticals Limited?
- What is Telix Pharmaceuticals Limited annual CFF year-on-year change?
What is Telix Pharmaceuticals Limited annual cash flow from financing activities?
The current annual CFF of TLX is $6.76 M
What is the all time high annual CFF for Telix Pharmaceuticals Limited?
Telix Pharmaceuticals Limited all-time high annual cash flow from financing activities is $121.52 M
What is Telix Pharmaceuticals Limited annual CFF year-on-year change?
Over the past year, TLX annual cash flow from financing activities has changed by -$114.76 M (-94.44%)